Prepregnancy Surgery Linked to Risk for Neonatal Abstinence Syndrome
Prescription opioids for postsurgical pain may lead to addiction that affects future pregnancies
Neonatal Abstinence Syndrome
Incidence of Neonatal Abstinence Syndrome Has More Than Doubled
The incidence of neonatal abstinence syndrome has steadily and notably increased in Canada and researchers believe this increase highlights the importance of implementing integrated care for the mother-infant dyad during and after the birth process.
County-Level Rates of Neonatal Abstinence Syndrome Indicative of Regional Unemployment Rates
Higher county-level rates of neonatal abstinence syndrome were associated with a regional shortage of mental health clinicians and high unemployment rates.
Buprenorphine May Be an Optimal Treatment for Neonatal Abstinence Syndrome
To identify the most effective treatment for NAS, study authors searched various databases for RCTs where a pharmacological agent was used alone or in combination with adjuvant treatments.
Smaller Heads Related to Opioid-Related Neonatal Abstinence Syndrome
Chronic opioid use during pregnancy that causes neonatal abstinence syndrome (NAS) is associated with smaller neonatal head circumference.
Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
Pregnant women receiving medication therapy for addiction can be prescribed higher doses of buprenorphine without increasing the risk or severity of neonatal abstinence syndrome.
Methadone Improves Short-Term Outcomes Better Than Morphine in Neonatal Abstinence Syndrome
Methadone may be superior to morphine for reducing hospital length of stay and length of drug treatment in infants with neonatal abstinence syndrome.
Methadone vs Buprenorphine During Pregnancy and Risk for Neonatal Abstinence Syndrome
Methadone exposure in utero was shown to increase the risk for neonatal abstinence syndrome compared with buprenorphine exposure.
Neonatal Withdrawal Risk Higher With Opioids Plus Psychotropic Drugs
The infants of women taking opioids concomitantly with psychotropic medications were found to have a substantially heightened risk of neonatal drug withdrawal.
Neonatal Abstinence Syndrome Effectively Treated With Buprenorphine
In infants with neonatal abstinence syndrome, sublingual buprenorphine reduced the duration of treatment and decreased the length of hospital stay.
